CHEMCRUX

Chemcrux Enterprises Limited

Chemcrux Enterprises Limited (CHEMCRUX) financial statements and selected valuation metrics through 30 June 2026.

Commodities›Chemicals›Chemicals & Petrochemicals›Specialty Chemicals

chemcrux.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹81.06
Market cap
120 Cr
Stock P/E
29.0
P/B
1.56
Dividend yield
1.2%
ROE (FY26)
4.9%
ROCE (FY26)
7.6%
Operating margin (FY26)
7.9%
Debt / equity (FY26)
0.44
OCF / EBITDA (FY26)
124.4%
OCF / EBITDA (3Y)
113.1%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

Company snapshot

65thBy market cap

Ranked among 68 companies in Specialty Chemicals.

What we see

Positives
  • ✓113% of operating profit came in as cash over the last three years — profits are backed by real cash.
1 more signal from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales19 Cr17 Cr18 Cr19 Cr16 Cr17 Cr18 Cr22 Cr24 Cr22 Cr
Operating expenses (approx.)16 Cr15 Cr15 Cr17 Cr14 Cr15 Cr16 Cr19 Cr20 Cr19 Cr
EBITDA3 Cr2 Cr2 Cr3 Cr2 Cr2 Cr2 Cr4 Cr4 Cr3 Cr
OPM %14.2%12.1%13.3%13.9%13.4%9.8%10.1%16.0%17.2%12.3%
Other income0.35 Cr0.39 Cr0.26 Cr0.61 Cr0.24 Cr0.44 Cr0.63 Cr0.60 Cr0.36 Cr0.11 Cr
Interest0.13 Cr0.13 Cr0.33 Cr0.60 Cr0.69 Cr0.86 Cr0.83 Cr0.76 Cr0.70 Cr0.64 Cr
Depreciation0.55 Cr0.56 Cr0.73 Cr0.92 Cr0.99 Cr1 Cr1 Cr1 Cr1 Cr1 Cr
Profit before tax2 Cr2 Cr2 Cr2 Cr0.67 Cr0.03 Cr0.40 Cr2 Cr3 Cr0.98 Cr
Tax %3.6%29.7%26.3%25.6%69.1%-200.0%46.2%27.9%30.7%48.5%
Net profit2 Cr1 Cr1 Cr1 Cr0.21 Cr0.09 Cr0.21 Cr2 Cr2 Cr0.51 Cr
EPS (₹)₹1.49₹0.84₹0.77₹0.89₹0.14₹0.06₹0.14₹1.06₹1.25₹0.34

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales78 Cr70 Cr81 CrSign in free for the trailing twelve months
Operating expenses (approx.)65 Cr61 Cr70 CrSign in free for the trailing twelve months
EBITDA13 Cr9 Cr11 CrSign in free for the trailing twelve months
OPM %16.8%13.2%13.8%Sign in free for the trailing twelve months
Other income1 Cr1 Cr2 CrSign in free for the trailing twelve months
Interest0.83 Cr2 Cr3 CrSign in free for the trailing twelve months
Depreciation2 Cr3 Cr5 CrSign in free for the trailing twelve months
Profit before tax11 Cr6 Cr5 CrSign in free for the trailing twelve months
Tax %26.1%32.1%29.4%Sign in free for the trailing twelve months
Net profit8 Cr4 Cr4 CrSign in free for the trailing twelve months
EPS (₹)₹5.70₹2.64₹2.52Sign in free for the trailing twelve months
Dividend payout %35.1%37.8%39.7%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital15 Cr15 Cr15 Cr
Reserves57 Cr60 Cr62 Cr
Borrowings26 Cr42 Cr34 Cr
Other liabilities12 Cr11 Cr17 Cr
Total liabilities110 Cr127 Cr127 Cr
Fixed assets (net)32 Cr76 Cr74 Cr
CWIP21 Cr2 Cr4 Cr
Investments21 Cr21 Cr17 Cr
Loans & advances0.23 Cr0.23 Cr0.20 Cr
Inventories8 Cr10 Cr6 Cr
Trade receivables15 Cr12 Cr19 Cr
Cash & bank0.08 Cr1 Cr2 Cr
Other assets12 Cr6 Cr5 Cr
Total assets110 Cr127 Cr127 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity17 Cr8 Cr14 Cr
Cash from investing-26 Cr-2 Cr-0.07 Cr
Cash from financing7 Cr-9 Cr-12 Cr
Net cash flow-2 Cr-4 Cr1 Cr
Free cash flow (OCF − Capex)-8 Cr-0.80 Cr9 Cr

Ratios

MetricMar 2024Mar 2025Mar 2026
ROCE %12.5%6.5%7.6%
ROE %11.7%5.2%4.9%
Debtor days716185
Inventory days12112278
Days payable10155119
Cash conversion cycle9112944
OCF / EBITDA %125.2%82.3%124.4%
OCF / EBITDA % (3 years)——113.1%
Debt / equity0.350.560.44
Current ratio3.882.311.89
Net debt / EBITDA1.934.392.82